- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/88 - Nitrogen atoms, e.g. allantoin
Patent holdings for IPC class C07D 233/88
Total number of patents in this class: 351
10-year publication summary
|
27
|
28
|
23
|
26
|
24
|
21
|
34
|
16
|
19
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SpringWorks Therapeutics, Inc. | 158 |
16 |
| Pfizer Inc. | 3426 |
14 |
| Novartis AG | 10160 |
9 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2326 |
9 |
| Epigen Biosciences, Inc. | 13 |
7 |
| Buck Institute for Research on Aging | 128 |
6 |
| Nippon Soda Co., Ltd. | 884 |
6 |
| Merck Sharp & Dohme LLC | 3734 |
6 |
| BASF SE | 21334 |
5 |
| The Regents of the University of California | 20987 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2685 |
5 |
| North Carolina State University | 1604 |
5 |
| Bristol-myers Squibb Company | 4751 |
4 |
| AstraZeneca AB | 2835 |
4 |
| Gilead Sciences, Inc. | 2259 |
4 |
| Katholieke Universiteit Leuven | 1307 |
4 |
| Romark Laboratories L.C. | 43 |
4 |
| Crystal Pharmaceutical (Suzhou) Co., Ltd. | 120 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6734 |
3 |
| BIAL - Portela & CA, S.A. | 213 |
3 |
| Other owners | 228 |